Collegium Pharmaceutical (COLL) Prepaid Assets (2014 - 2026)
Collegium Pharmaceutical (COLL) posted Prepaid Assets of $60.3 million for Q2 2026, up 85.27% on a QoQ basis from $32.6 million in Q1 2026, and up 7.65% year-over-year from $56.0 million in Q2 2025.
Analysis
Collegium Pharmaceutical (COLL) Prepaid Assets (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical has reported Prepaid Assets for 13 years, with the latest figure at $60.3 million in Q2 2026.
- On a quarterly basis, Prepaid Assets rose 7.65% year-over-year to $60.3 million in Q2 2026; TTM through Jun 2026 was $60.3 million, a 7.65% increase from a year earlier, with the FY2025 full-year figure at $32.6 million, up 7.4% from the prior year.
- Prepaid Assets was $60.3 million for Q2 2026 at Collegium Pharmaceutical, up from $32.6 million in the prior quarter.
- The five-year high for Prepaid Assets was $60.3 million in Q2 2026, with the low at $10.4 million in Q1 2022.
- Average Prepaid Assets over 5 years is $26.9 million, with a median of $22.6 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2026: Prepaid Assets soared 203.19% in 2022, then slipped 25.99% in 2026.
- Over 5 years, Prepaid Assets stood at $16.7 million in 2022, then fell by 8.91% to $15.2 million in 2023, then jumped by 100.03% to $30.4 million in 2024, then rose by 7.4% to $32.6 million in 2025, then jumped by 84.81% to $60.3 million in 2026.
- The last three Prepaid Assets figures came in at $60.3 million (Q2 2026), $32.6 million (Q1 2026), and $32.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Collegium Pharmaceutical | 753.09 Mn | 603.77 Mn | 110.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.33 Mn |
| Mar 31, 2026 | 32.56 Mn |
| Dec 31, 2025 | 32.64 Mn |
| Sep 30, 2025 | 36.16 Mn |
| Jun 30, 2025 | 56.04 Mn |
| Mar 31, 2025 | 44.00 Mn |
| Dec 31, 2024 | 30.39 Mn |
| Sep 30, 2024 | 32.37 Mn |
| Jun 30, 2024 | 26.85 Mn |
| Mar 31, 2024 | 15.24 Mn |
| Dec 31, 2023 | 15.20 Mn |
| Sep 30, 2023 | 16.55 Mn |
| Jun 30, 2023 | 18.32 Mn |
| Mar 31, 2023 | 16.80 Mn |
| Dec 31, 2022 | 16.68 Mn |
| Sep 30, 2022 | 11.04 Mn |
| Jun 30, 2022 | 11.78 Mn |
| Mar 31, 2022 | 10.45 Mn |
| Dec 31, 2021 | 5.88 Mn |
| Sep 30, 2021 | 3.64 Mn |